Nanoscale carriers for targeted delivery of drugs and therapeutic biomolecules

Canadian Journal of Chemical Engineering

Volumn 91, Issue 4, 2013, Pages 638-651

  Kiparissides, Costas ^a,b   Kammona, Olga ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Centre for Research and Technology Hellas   (Greece)

Author keywords

Administration routes; Biomolecules; Functionalisation; Nanocarrier based drug delivery systems; Targeting

Indexed keywords

BIOLOGICAL MEDIA; CONVENTIONAL DRUGS; DRUG DELIVERY SYSTEM; FUNCTIONALISATION; LOW COSTS; NANO SCALE; NANO-CARRIERS; NASAL ADMINISTRATION; NON-TOXIC; TARGETED DELIVERY; TARGETED DELIVERY SYSTEMS; TARGETED DRUG DELIVERY; TARGETING; THERAPEUTIC AGENTS;

DRUG DELIVERY;

BIOMOLECULES;

EID: 84874770344     PISSN: 00084034     EISSN: 1939019X     Source Type: Journal    
DOI: 10.1002/cjce.21685     Document Type: Article

References (120)

1. Adair, J. H., M. P. Parette, E. I. Altinoglu and M. Kester, "Nanoparticulate Alternatives for Drug Delivery, "ACS Nano. 4(9), 4967-4970 (2010).
2. Aguzzi, C., P. Cerezo, C. Viseras and C. Caramella, "Use of Clays as Drug Delivery Systems: Possibilities and Limitations, "Appl. Clay Sci. 36, 22-36 (2007).
3. Aiertza, M. K., I. Odriozola, G. Cabañero, H.-J. Grande and I. Loinaz, "Single-chain Polymer Nanoparticles, "Cell. Mol. Life Sci. 69(3), 337-346 (2012).
4. Ainbinder, D., D. Paolino, M. Fresta and E. Touitou, "Drug Delivery Applications with Ethosomes, "J. Biomed. Nanotechnol. 6(5), 558-568 (2010).
5. Akiladevi, D. and S. Basak, "Ethosomes a Noninvasive Approach for Transdermal Drug Delivery, "Int. J. Curr. Pharm. Res. 2(4), 1-4 (2010).
6. Al-Jamal, W. T. and K. Kostarelos, "Liposome-nanoparticle Hybrids for Multimodal Diagnostic and Therapeutic Applications, "Nanomedicine 2, 85-98 (2007).
7. Antosova, Z., M. Mackova, V. Kral and T. Macek, "Therapeutic Application of Peptides and Proteins: Parenteral Forever?" Trends Biotechnol. 27(11), 628-635 (2009).
8. Bae, Y., S. Fukushima, A. Harada and K. Kataoka, "Design of Environment-Sensitive Supramolecular Assemblies for Intracellular Drug Delivery: Polymeric Micelles That Are Responsive to Intracellular pH Change, "Angew. Chem. Int. Ed. 42, 4640-4643 (2003).
9. Bernkop-Schnürch, A., M. Hornof and D. Guggi, "Thiolated Chitosans, "Eur. J. Pharm. Biopharm. 57, 9-17 (2004).
10. Bhattacharyya, S., R. A. Kudgus, R. Bhattacharya and P. Mukherjee, "Inorganic Nanoparticles in Cancer Therapy, "Pharm. Res. 28, 237-259 (2011).
11. Blanco, E., A. Hsiao, A. P. Mann, M. G. Landry, F. Meric-Bernstam and M. Ferrari, "Nanomedicine in Cancer Therapy: Innovative Trends and Prospects, "Cancer Sci. 102, 1247-1252 (2011).
12. Bowman, K. and K. W. Leong, "Chitosan Nanoparticles for Oral Drug and Gene Delivery, "Int. J. Nanomed. 1, 117-128 (2006).
13. Bunjes, H., "Lipid nanoparticles for the Delivery of Poorly Water-Soluble Drugs, "J. Pharm. Pharmacol. 62(11), 1637-1645 (2011).
14. Buse, J. and A. El-Aneed, "Properties, Engineering and Applications of Lipid-based Nanoparticle Drug-Delivery Systems: Current Research and Advances, "Nanomedicine (Lond). 5(8), 1237-1260 (2010).
15. Byrne, M. E., K. Park and N. A. Peppas, "Molecular Imprinting within Hydrogels, "Adv. Drug Deliv. Rev. 54, 149-161 (2002).
16. Caldorera-Moore, M., N. Guimard, L. Shi and K. Roy, "Designer Nanoparticles: Incorporating Size, Shape, and Triggered Release into Nanoscale Drug Carriers, "Expert Opin. Drug Deliv. 7(4), 479-495 (2010).
17. Celardo, I., J. Z. Pedersen, E. Traversa and L. Ghibelli, "Pharmacological Potential of Cerium Oxide Nanoparticles, "Nanoscale 3(4), 1411-1420 (2011).
18. Chan, H.-K. and P. C. L. Kwok, "Production Methods for Nanodrug Particles Using the Bottom-up Approach, "Adv. Drug Deliv. Rev. 63, 406-416 (2011).
19. Chen, C., D. Han, C. Cai and X. Tang, "An Overview of Liposome Lyophilisation and its Future Potential, "J. Control. Release 142(3), 299-311 (2010).
20. Chen, M.-C., K. Sonaje, K.-J. Chen and H.-W. Sung, "A Review of the Prospects for Polymeric Nanoparticle Platforms in Oral Insulin Delivery, "Biomaterials 32, 9826-9838 (2011).
21. Cheng, Y., L. Zhao, Y. Li and T. Xu, "Design of Biocompatible Dendrimers for Cancer Diagnosis and Therapy: Current Status and Future Perspectives, "Chem. Soc. Rev. 40(5), 2673-2703 (2011).
22. Choi, Y. S., J. Y. Lee, J. S. Suh, S. J. Lee, V. C. Yang, C. P. Chung and Y. J. Park, "Cell Penetrating Peptides for Tumour Targeting, "Curr. Pharm. Biotechnol. 12(8), 1166-1182 (2011).
23. Conde, J., G. Doria and P. Baptista, "Noble Metal Nanoparticles Applications in Cancer, "J. Drug Deliv. 2012, (2012). Article ID 751075, 12 pages.
24. Costantino, H. R., L. Illum, G. Brandt, P. H. Johnson and S. C. Quay, "Intranasal Delivery: Physicochemical and Therapeutic Aspects, "Int. J. Pharm. 337, 1-24 (2007).
25. Cryan, S.-A., "Carrier-based Strategies for Targeting Protein and Peptide Drugs to the Lungs, "AAPS J. 7(1), E20-E41 (2005).
26. Dailey, L. A. and T. Kissel, "New Poly(lactic-co-glycolic acid) Derivatives: Modular Polymers with Tailored Properties, "Drug Discov. Today: Technol. 2(1), 7-13 (2005).
27. Dash, T. K. and V. B. Konkimalla, "Poly-ε-caprolactone Based Formulations for Drug Delivery and Tissue Engineering: A Review, "J. Control. Release 158, 15-33 (2012).
28. Decuzzi, P., R. Pasqualini, W. Arap and M. Ferrari, "Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?" Pharm. Res. 26(1), 235-243 (2009).
29. del Pozo-Rodriguez, A., D. Delgado, M. A. Solinis and A. R. Gascon, "Lipid Nanoparticles as Vehicles for Macromolecules: Nucleic Acids and Peptides, "Recent Pat. Drug Deliv. Formul. 5(3), 214-226 (2011).
30. Desimone, M. F., M. L. Foglia, G. S. Alvarez, P. N. Catalano, A. M. Mebert, L. E. Diaz and T. Coradin, "Recent Patents on the Synthesis and Application of Silica Nanoparticles for Drug Delivery, "Recent Pat. Biotechnol. 5(1), 54-61 (2011).
31. Dinarvand, R., N. Sepehri, S. Manoochehri, H. Rouhani and F. Atyabil, "Polylactide-co-glycolide Nanoparticles for Controlled Delivery of Anticancer Agents, "Int. J. Nanomed. 6, 877-895 (2011).
32. Dobson, J., "Magnetic Micro- and Nano-particle-based Targeting for Drug and Gene Delivery, "Nanomedicine 1, 31-37 (2006).
33. Elsayed, M. M. A., O. Y. Abdallah, V. F. Naggar and N. M. Khalafallah, "Lipid Vesicles for Skin Delivery of Drugs: Reviewing Three Decades of Research, "Int. J. Pharm. 332, 1-16 (2007).
34. Elzoghby, A. O., W. M. Samy and N. A. Elgindy, "Albumin-based Nanoparticles as Potential Controlled Release Drug Delivery Systems, "J. Control. Release 157(2), 168-182 (2012).
35. Ferrari, M., "The Mathematical Engines of Nanomedicine, "Small 4(1), 20-25 (2008).
36. Frimpong, R. A. and J. Z. Hilt, "Magnetic Nanoparticles in Biomedicine: Synthesis, Functionalisation and Applications, "Nanomedicine (Lond). 5(9), 1401-1414 (2010).
37. Gao, Y., X.-L. Liu and X.-R. Li, "Research Progress on siRNA Delivery with Nonviral Carriers, "Int. J. Nanomed. 6, 1017-1025 (2011).
38. Giri, S., B. G. Trewyn and V. S. Lin, "Mesoporous Silica Nanomaterial-based Biotechnological and Biomedical Delivery Systems, "Nanomedicine 2, 99-111 (2007).
39. Grabnar, P. A. and J. Kristl, "The Manufacturing Techniques of Drug-loaded Polymeric Nanoparticles from Preformed Polymers, "J. Microencapsul. 28(4), 323-335 (2011).
40. Günther, M., J. Lipka, A. Malek, D. Gutsch, W. Kreyling and A. Aigner, "Polyethylenimines for RNAi-mediated Gene Targeting In Vivo and siRNA Delivery to the Lung, "Eur. J. Pharm. Biopharm. 77, 438-449 (2011).
41. Haag, R., "Supramolecular Drug-Delivery Systems Based on Polymeric Core-Shell Architectures, "Angew. Chem. Int. Ed. 43, 278-282 (2004).
42. Han, G., P. Ghosh and V. M. Rotello, "Functionalised Gold Nanoparticles for Drug Delivery, "Nanomedicine 2, 113-123 (2007).
43. Huang, H.-C., S. Barua, G. Sharma, S. K. Dey and K. Rege, "Inorganic Nanoparticles for Cancer Imaging and Therapy, "J. Control. Release 155, 344-357 (2011).
44. Huynh, L., C. Neale, R. Pomès and C. Allen, "Computational Approaches to the Rational Design of Nanoemulsions, Polymeric Micelles, and Dendrimers for Drug Delivery, "Nanomed. Nanotechnol. 8, 20-36 (2012).
45. Huynh, N. T., E. Roger, N. Lautram, J. P. Benoît and C. Passirani, "The Rise and Rise of Stealth Nanocarriers for Cancer Therapy: Passive Versus Active Targeting, "Nanomedicine (Lond). 5(9), 1415-1433 (2010).
46. Immordino, M. L., F. Dosio and L. Cattel, "Stealth Liposomes: Review of the Basic Science, Rationale, and Clinical Applications, Existing and Potential, "Int. J. Nanomed. 1, 297-315 (2006).
47. Jain, J. P., W. Y. Ayen and N. Kumar, "Self Assembling Polymers as Polymersomes for Drug Delivery, "Curr. Pharm. Des. 17(1), 65-79 (2011a).
48. Jain, A. K., M. Das, N. K. Swarnakar and S. Jain, "Engineered PLGA Nanoparticles: An Emerging Delivery Tool in Cancer Therapeutics, "Crit. Rev. Ther. Drug Carrier Syst. 28(1), 1-45 (2011b).
49. Jarmila, V. and E. Vavríková, "Chitosan Derivatives with Antimicrobial, Antitumour and Antioxidant Activities-A Review, "Curr. Pharm. Des. 17(32), 3596-3607 (2011).
50. Jølck, R. I., L. N. Feldborg, S. Andersen, S. Moein Moghimi and T. L. Andresen, "Engineering Liposomes and Nanoparticles for Biological Targeting, "Adv. Biochem. Eng./Biotechnol. 125, 251-280 (2011).
51. Kenneth, K. N. G., J. F. Lovell and G. Zheng, "Lipoprotein-Inspired Nanoparticles for Cancer Theranostics, "Accounts Chem. Res. 44(10), 1105-1113 (2011).
52. Khademhosseini, A. and R. Langer, "Drug Delivery and Tissue Engineering, "Chem. Eng. Prog. 102(2), 38-42 (2006). CEP Magazine, SBE Special Section.
53. Kim, J.-E., J.-Y. Shin and M.-H. Cho, "Magnetic Nanoparticles: An Update of Application for Drug Delivery and Possible Toxic Effects, "Arch. Toxicol. (2011). DOI: 10.1007/s00204-011-0773-3
54. Kingsley, J. D., H. Dou, J. Morehead, B. Rabinow, H. E. Gendelman and Ch. J. Destache, "Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System, "J. Neuroimmune Pharmacol. 1, 340-350 (2006).
55. Kiparissides, C. and O. Kammona, "Nanotechnology Advances in Controlled Drug Delivery Systems, "Phys. Stat. Sol. (c) 5(12), 3828-3833 (2008).
56. Kiparissides, C., S. Alexandridou, K. Kotti and S. Chaitidou, "Recent Advances in Novel Drug Delivery Systems, "AZojono (J. Nanotechnol. Online) 2, 1-11 (2006).
57. Krauland, A. H. and M. J. Alonso, "Chitosan/Cyclodextrin Nanoparticles as Macromolecular Drug Delivery System, "Int. J. Pharm. 340, 134-142 (2007).
58. Kudgus, R. A., R. Bhattacharya and P. Mukherjee, "Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates, "Anticancer Agents Med. Chem. 11(10), 965-973 (2011).
59. Laurent, S., J. L. Bridot, L. V. Elst and R. N. Muller, "Magnetic Iron Oxide Nanoparticles for Biomedical Applications, "Future Med. Chem. 2(3), 427-449 (2010).
60. Lee, J. S. and J. Feijen, "Polymersomes for Drug Delivery: Design, Formation and Characterisation, "J. Control. Release (2011). DOI: 10.1016/j.jconrel.2011.10.005
61. Lembo, D. and R. Cavalli, "Nanoparticulate Delivery Systems for Antiviral Drugs, "Antivir. Chem. Chemother. 21(2), 53-70 (2010).
62. Li, Y. and T. Hou, "Computational Simulation of Drug Delivery at Molecular Level, "Curr. Med. Chem. 17(36), 4482-4491 (2010).
63. Liu, B. R., Y.-W. Huang, H.-J. Chiang and H.-J. Lee, "Cell-Penetrating Peptide-Functionised Quantum Dots for Intracellular Delivery, "J. Nanosci. Nanotechnol. 10(12), 7897-7905 (2010).
64. Liu, J., T. Gong, C. Wang, Z. Zhong and Z. Zhang, "Solid Lipid nanoparticles Loaded with Insulin by Sodium Cholate-Phosphatidylcholine-Based Mixed Micelles: Preparation and Characterisation, "Int. J. Pharm. 340, 153-162 (2007).
65. Malam, Y., E. J. Lim and A. M. Seifalian, "Current Trends in the Application of Nanoparticles in Drug Delivery, "Curr. Med. Chem. 18(7), 1067-1078 (2011).
66. Manocha, M., P. C. Pal, K. T. Chitralekha, B. E. Thomas, V. Tripathi, S. D. Gupta, R. Paranjape, S. Kulkarni and D. N. Rao, "Enhanced Mucosal and Systemic Immune Response with Intranasal Immunisation of Mice with HIV Peptides Entrapped in PLG Microparticles in Combination with Ulex Europaeus-I Lectin as M Cell Target, "Vaccine 23, 5599-5617 (2005).
67. Mansour, H. M., Y.-S. Rhee and X. Wu, "Nanomedicine in Pulmonary Delivery, "Int. J. Nanomed. 4, 299-319 (2009).
68. Mizrahy, S. and D. Peer, "Polysaccharides as Building Blocks for Nanotherapeutics, "Chem. Soc. Rev. 41(7), 2623-2640 (2012).
69. Mody, V. V., R. Siwale, A. Singh and H. R. Mody, "Introduction to Metallic Nanoparticles, "J. Pharm. Bioallied. Sci. 2(4), 282-289 (2010).
70. Mufamadi, M. S., V. Pillay, Y. E. Choonara, L. C. Du Toit, G. Modi, D. Naidoo and V. M. K. Ndesendo, "A Review on Composite Liposomal Technologies for Specialised Drug Delivery, "J. Drug Deliv. 2011, (2011). Article ID 939851, 19 pages.
71. Müller-Goymann, C. C., "Physicochemical Characterisation of Colloidal Drug Delivery Systems such as Reverse Micelles, Vesicles, Liquid Crystals and Nanoparticles for Topical Administration, "Eur. J. Pharm. Biopharm. 58, 343-356 (2004).
72. Müller, R. H., S. Gohla and C. M. Keck, "State of the Art of Nanocrystals-Special Features, Production, Nanotoxicology Aspects and Intracellular Delivery, "Eur. J. Pharm. Biopharm. 78, 1-9 (2011).
73. Musacchio, T. and V. P. Torchilin, "Recent Developments in Lipid-based Pharmaceutical Nanocarriers, "Front. Biosci. 16, 1388-1412 (2011).
74. Nagpal, K., S. K. Singh and D. N. Mishra, "Chitosan Nanoparticles: A Promising System in Novel Drug Delivery, "Chem. Pharm. Bull. 58(11), 1423-1430 (2010).
75. Nanomedicine: Nanotechnology for Health, European Technology Platform, Strategic Research Agenda for Nanomedicine, November (2006). http://cordis.europa.eu/nanotechnology/nanomedicine.htm
76. Nimesh, S., N. Gupta and R. Chandra, "Cationic Polymer Based Nanocarriers for Delivery of Therapeutic Nucleic Acids, "J. Biomed. Nanotechnol. 7(4), 504-520 (2011).
77. Paleos, C. M., D. Tsiourvas and Z. Sideratou, "Molecular Engineering of Dendritic Polymers and Their Application as Drug and Gene Delivery Systems, "Mol. Pharm. 4(2), 169-188 (2007).
78. Paleos, C. M., D. Tsiourvas, Z. Sideratou and L. A. Tziveleka, "Drug Delivery Using Multifunctional Dendrimers and Hyperbranched Polymers, "Expert Opin. Drug Deliv. 7(12), 1387-1398 (2010).
79. Pan, H., N. R. Soman, P. H. Schlesinger, G. M. Lanza and S. A. Wickline, "Cytolytic Peptide Nanoparticles ('NanoBees') for Cancer Therapy, "WIREs Nanomed. Nanobiotechnol. 3, 318-327 (2011).
80. Parveen, S., R. Misra and S. K. Sahoo, "Nanoparticles: A Boon to Drug Delivery, Therapeutics, Diagnostics and Imaging, "Nanomed. Nanotechnol. 8(2), 147-166 (2012).
81. Pathak, K., L. Keshri and M. Shah, "Lipid Nanocarriers: Influence of Lipids on Product Development and Pharmacokinetics, "Crit. Rev. Ther. Drug Carrier Syst. 28(4), 357-393 (2011).
82. Patidar, A., D. S. Thakur, P. Kumar and J. Verma, "A Review on Novel Lipid Based Nanocarriers, "Int. J. Pharm. Pharm. Sci. 2(4), 30-35 (2010).
83. Petkar, K. C., S. S. Chavhan, S. Agatonovik-Kustrin and K. K. Sawant, "Nanostructured Materials in Drug and Gene Delivery: A Review of the State of the Art, "Crit. Rev. Ther. Drug Carrier Syst. 28(2), 101-164 (2011).
84. Popat, A., S. B. Hartono, F. Stahr, J. Liu, S. Z. Qiao and G. Qing Max Lu, "Mesoporous Silica Nanoparticles for Bioadsorption, Enzyme Immobilisation, and Delivery Carriers, "Nanoscale 3(7), 2801-2818 (2011).
85. Preiss, M. R. and G. D. Bothun, "Stimuli-responsive Liposome-Nanoparticle Assemblies, "Expert Opin. Drug Deliv. 8(8), 1025-1040 (2011).
86. Pritchard, E. M. and D. L. Kaplan, "Silk Fibroin Biomaterials for Controlled Release Drug Delivery, "Expert Opin. Drug. Deliv. 8(6), 797-811 (2011).
87. Puri, A., K. Loomis, B. Smith, J.-H. Lee, A. Yavlovich, E. Heldman and R. Blumenthal, "Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic, "Crit. Rev. Ther. Drug Carrier Syst. 26(6), 523-580 (2009).
88. Qi, X., L. Wang, J. Zhu, Z. Hu and J. Zhang, "Self-Double-Emulsifying Drug Delivery System (SDEDDS): A New Way for Oral Delivery of Drugs with High Solubility and Low Permeability, "Int. J. Pharm. 409, 245-251 (2011).
89. Rajpoot, P., K. Pathak and V. Bali, "Therapeutic Applications of Nanoemulsion based Drug Delivery Systems: A Review of Patents in Last Two Decades, "Recent Pat. Drug Deliv. Formul. 5(2), 163-172 (2011).
90. Rana, S., A. Bajaj, R. Mout and V. M. Rotello, "Monolayer Coated Gold Nanoparticles for Delivery Applications, "Adv. Drug Deliv. Rev. 64(2), 200-216 (2012).
91. Rawat, M., D. Singh, S. Saraf and S. Saraf, "Lipid Carriers: A Versatile Delivery Vehicle for Proteins and Peptides, "Yakugaku Zasshi 128(2), 269-280 (2006).
92. Rodríguez-Hernández, J. and S. Lecommandoux, "Reversible Inside-Out Micellisation of pH-responsive and Water-Soluble Vesicles Based on Polypeptide Diblock Copolymers, "J. Am. Chem. Soc. 127, 2026-2027 (2005).
93. Rösler, A., G. W. M. Vandermeulen and H.-A. Klok, "Advanced Drug Delivery Devices via Self-Assembly of Amphiphilic Block Copolymers, "Adv. Drug Deliv. Rev. 53, 95-108 (2001).
94. Ruan, J., J. Liu, D. Zhua, T. Gong, F. Yang, X. Hao and Z. Zhang, "Preparation and Evaluation of Self-Nanoemulsified Drug Delivery Systems (SNEDDSs) of Matrine Based on Drug-Phospholipid Complex Technique, "Int. J. Pharm. 386, 282-290 (2010).
95. Samad, A., Y. Sultana and M. Aqil, "Liposomal Drug Delivery Systems: An Update Review, "Curr. Drug Deliv. 4, 297-305 (2007).
96. Schäfer, J., S. Höbel, U. Bakowsky and A. Aigner, "Liposome-Polyethylenimine Complexes for Enhanced DNA and siRNA Delivery, "Biomaterials 31, 6892-6900 (2010).
97. Schubert, M. A., M. Harms and C. C. Muller-Goymann, "Structural Investigations on Lipid Nanoparticles Containing High Amounts of Lecithin, "Eur. J. Pharm. Sci. 27(2-3), 226-236 (2006).
98. Shi, J., Z. Xiao, N. Kamaly and O. C. Farokhzad, "Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation, "Acc. Chem. Res. 44(10), 1123-1134 (2011).
99. Simovic, S., N. Ghouchi-Eskandar, A. M. Sinn, D. Losic and C. A. Prestidge, "Silica Materials in Drug Delivery Applications, "Curr. Drug Discov. Technol. 8(3), 269-276 (2011).
100. Singh, R., S. Singh and J. W. Lillard, "Past, Present, and Future Technologies for Oral Delivery of Therapeutic Proteins, "J. Pharm. Sci. 97(7), 2497-2523 (2008).
101. Singh, S., "Nanomedicine-Nanoscale Drugs and Delivery Systems, "J. Nanosci. Nanotechnol. 10(12), 7906-7918 (2010).
102. Slomkowski, S. and M. Gosecki, "Progress in Nanoparticulate Systems for Peptide, Proteins and Nucleic Acid Drug Delivery, "Curr. Pharm. Biotechnol. 12(11), 1823-1839 (2011).
103. Sood, A. and R. Panchagnula, "Reporal Route: An Opportunity for Protein and Peptide Drug Delivery, "Chem. Rev. 101, 3275-3303 (2001).
104. Souto, E. B., A. P. Nayak and R. S. Murthy, "Lipid Nanoemulsions for Anti-cancer Drug Therapy, "Pharmazie 66(7), 473-478 (2011).
105. Stark, W. J., "Nanoparticles in Biological Systems, "Angew. Chem. Int. Ed. 50, 1242-1258 (2011).
106. Sutton, D., N. Nasongkla, E. Blanco and J. Gao, "Functionalised Micellar Systems for Cancer Targeted Drug Delivery, "Pharm. Res. 24, 1029-1046 (2007).
107. Tao, L., W. Hu, Y. Liu, G. Huang, B. D. Sumer and J. Gao, "Shape-specific Polymeric Nanomedicine: Emerging Opportunities and Challenges, "Exp. Biol. Med. 236, 20-29 (2011).
108. Teijeiro-Osorio, D., C. Remuñán-López and M. J. Alonso, "New Generation of Hybrid Poly/Oligosaccharide Nanoparticles as Carriers for the Nasal Delivery of Macromolecules, "Biomacromolecules 10, 243-249 (2009).
109. Torchilin, V. P., "Structure and Design of Polymeric Surfactant-based Drug Delivery Systems, "J. Control. Release 73, 137-172 (2001).
110. Touitou, E., N. Dayan, L. Bergelson, B. Godin and M. Eliaz, "Ethosomes-Novel Vesicular Carriers for Enhanced Delivery: Characterisation and Skin Penetration Properties, "J. Control. Release 65, 403-418 (2000).
111. Ugwoke, M. I., R. M. Agu, N. Verbeke and R. Kinget, "Nasal Mucoadhesive Drug Delivery: Background, Applications, Trends and Future Perspectives, "Adv. Drug Deliv. Rev. 57, 1640-1665 (2005).
112. Vandermeulen, G. W. M. and H.-A. Klok, "Peptide/Protein Hybrid Materials: Enhanced Control of Structure and Improved Performance through Conjugation of Biological and Synthetic Polymers, "Macromol. Biosci. 4, 383-398 (2004).
113. Venkata Ramana Rao, S. and J. Shao, "Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Oral Delivery of Protein Drugs I. Formulation Development, "Int. J. Pharm. 362, 2-9 (2008).
114. Vrignaud, S., J.-P. Benoit and P. Saulnier, "Strategies for the Nanoencapsulation of Hydrophilic Molecules in Polymer-based Nanoparticles, "Biomaterials 32, 8593-8604 (2011).
115. Wang, J. J., Z. W. Zeng, R. Z. Xiao, T. Xie, G. L. Zhou, X. R. Zhan and S. L. Wang, "Recent Advances of Chitosan Nanoparticles as Drug Carriers, "Int. J. Nanomed. 6, 765-774 (2011).
116. Wenk, E., H. P. Merkle and L. Meinel, "Silk Fibroin as a Vehicle for Drug Delivery Applications, "J. Control. Release 150, 128-141 (2011).
117. Xiao, R. Z., Z. W. Zeng, G. L. Zhou, J. J. Wang, F. Z. Li and A. M. Wang, "Recent Advances in PEG-PLA Block Copolymer Nanoparticles, "Int. J. Nanomed. 5, 1057-1065 (2010).
118. Xiong, X.-B., A. Falamarzian, S. M. Garg and A. Lavasanifar, "Engineering of Amphiphilic Block Copolymers for Polymeric Micellar Drug and Gene Delivery, "J. Control. Release 155, 248-261 (2011).
119. Yoo, J.-W., N. Doshi and S. Mitragotri, "Adaptive Micro and Nanoparticles: Temporal Control Over Carrier Properties to Facilitate Drug Delivery, "Adv. Drug Deliv. Rev. 63, 1247-1256 (2011).
120. Yuan, X., S. Naguib and Z. Wu, "Recent Advances of siRNA Delivery by Nanoparticles, "Expert Opin. Drug Deliv. 8(4), 521-536 (2011).